Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00735111 · ClinicalTrials.gov registry record · NA

Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?

A NA study of Cancer, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT00735111: Completed NA study of Cancer, sponsored by University of Florida.

NCT00735111 is a NA study of Cancer that has completed, run by University of Florida. The registered enrollment target is 200 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00735111, a NA study of Cancer, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if patients are able to self-rate their physical abilities and how these ratings compare to the ratings of their health-care provider.

Conditions Studied

Interventions

  • OTHER Karnofsky Performance Status Score

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2008-02
Est. Completion 2011-11
Phase NA
University of Florida

1,106 total trials

What the finished NCT00735111 record still lists

NCT00735111 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Karnofsky Performance Status Score is the first listed.

NCT00735111 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT00735111 about?

NCT00735111 is a clinical study titled "Do Self-Rated Performance Status Scores Correlate With Health-Care-Provider-Scores?". The purpose of this study is to determine if patients are able to self-rate their physical abilities and how these ratings compare to the ratings of their health-care provider.

What is the current status of trial NCT00735111?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2008-02. Estimated completion is 2011-11.

What conditions does trial NCT00735111 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT00735111?

The interventions under investigation include: Karnofsky Performance Status Score (OTHER).

Who is sponsoring clinical trial NCT00735111?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00735111 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00735111's enrollment target sits among peer trials

200 231st of 615 higher than 380 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00735111, the US trial registry maintained by the National Library of Medicine. NCT00735111 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.